These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15037816

  • 1. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice.
    Sounvoravong S, Takahashi M, Nakashima MN, Nakashima K.
    J Pharmacol Sci; 2004 Mar; 94(3):305-12. PubMed ID: 15037816
    [Abstract] [Full Text] [Related]

  • 2. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M, Senda T, Kaneto H.
    Eur J Pharmacol; 1991 Aug 06; 200(2-3):293-7. PubMed ID: 1664330
    [Abstract] [Full Text] [Related]

  • 3. Interactions of cocaine with morphine, U-50,488H and [D-Pen2, D-Pen5]enkaphalin.
    Bhargava HN, Cao YJ.
    Peptides; 1998 Aug 06; 19(3):563-8. PubMed ID: 9533646
    [Abstract] [Full Text] [Related]

  • 4. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug 06; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 5. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
    Bhargava HN, Thorat SN.
    Brain Res; 1994 Jun 27; 649(1-2):111-6. PubMed ID: 7953621
    [Abstract] [Full Text] [Related]

  • 6. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J, Narita M, Suzuki M, Yajima Y, Suzuki T.
    Neuropharmacology; 2004 Mar 27; 46(4):531-40. PubMed ID: 14975677
    [Abstract] [Full Text] [Related]

  • 7. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
    Bileviciute-Ljungar I, Spetea M.
    Br J Pharmacol; 2001 Jan 27; 132(1):252-8. PubMed ID: 11156584
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J, Ohhashi Y, Aoki T, Kawasima N, Kasuya Y.
    Brain Res; 1992 Feb 07; 571(2):199-203. PubMed ID: 1319265
    [Abstract] [Full Text] [Related]

  • 10. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN, Ramarao P, Gulati A.
    Eur J Pharmacol; 1989 Mar 21; 162(2):257-64. PubMed ID: 2542058
    [Abstract] [Full Text] [Related]

  • 11. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
    Narita M, Khotib J, Mizoguchi H, Suzuki M, Ozaki S, Yajima Y, Tseng LF, Suzuki T.
    Eur J Neurosci; 2003 Nov 21; 18(9):2498-504. PubMed ID: 14622150
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T, Ohno M, Ueki S.
    Eur J Pharmacol; 1988 Oct 26; 156(1):173-6. PubMed ID: 2850208
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
    Bhargava HN, Thorat SN.
    Brain Res; 1997 Feb 07; 747(2):246-51. PubMed ID: 9045999
    [Abstract] [Full Text] [Related]

  • 15. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
    Suh HW, Song DK, Huh SO, Kim YH.
    Planta Med; 2000 Jun 07; 66(5):412-7. PubMed ID: 10909259
    [Abstract] [Full Text] [Related]

  • 16. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
    Laurido C, Hernandez A, Perez H.
    Int J Neurosci; 1996 Nov 07; 87(3-4):191-9. PubMed ID: 9003979
    [Abstract] [Full Text] [Related]

  • 17. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
    Diop L, Rivière PJ, Pascaud X, Junien JL.
    Eur J Pharmacol; 1994 Dec 12; 271(1):65-71. PubMed ID: 7698213
    [Abstract] [Full Text] [Related]

  • 18. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B, McLemore G, Kao B, Inturrisi CE.
    J Pharmacol Exp Ther; 1997 Dec 12; 283(3):1249-55. PubMed ID: 9400000
    [Abstract] [Full Text] [Related]

  • 19. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
    Gullapalli S, Ramarao P.
    Neuropharmacology; 2002 Mar 12; 42(4):467-75. PubMed ID: 11955518
    [Abstract] [Full Text] [Related]

  • 20. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
    Suh HW, Chung KM, Kim YH, Huh SO, Song DK.
    Neuropeptides; 1999 Apr 12; 33(2):121-9. PubMed ID: 10657481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.